Table 2.

Effect of Cisplatin (CisPT) and different treatments of AHE on Brain POD, SOD, CAT, and QR levels

Treatment (mg/kg)	POD (U/min)	SOD (U/mg protein)	CAT (U/min)	QR (nM/min/mg protein)
Control	11.85 ± 0.130+++	1.812 ± 0.060+++	35.50 ± 0.289+++	93.49 ± 0.526+++
CisPT	5.170 ± 0.383**	0.541 ± 0.050***	18.43 ± 0.251***	63.55 ± 1.275***
AHE alone	11.30 ± 0.185+++	1.831 ± 0.071+++	35.93 ± 0.479+++	93.84 ± 0.140+++
AHE (200) + CisPT	8.010 ± 0.151**,+++	1.165 ± 0.098**,+++	26.96 ± 0.248***,+++	73.32 ± 0.667***,+++
AHE (400) + CisPT	10.14 ± 0.203+++,##	1.697 ± 0.083+++,##	30.08 ± 0.107*,+++,##	83.22 ± 0.491**,+++,##
Sily + CisPT	10.12 ± 0.196+++	1.675 ± 0.066+++	30.19 ± 0.335*,+++	83.11 ± 0.537 **,+++

Data expressed as mean ± SEM (n = 8). Astericks ^*, ^**, ^*** indicted significant difference of final body weight of group Vs. Control group at p < 0.05, p < 0.001 and p < 0.0001 respectively, ^{++, +++} indicated significant difference of final body weight of group Vs. CisPT-treated group at p < 0.001 and p < 0.0001 respectively, ^## indicated significant difference of final body weight of AHE (200 mg/kg) + CisPT treated group Vs. AHE (400 mg/kg) + CisPT treated group at p < 0.001. Non-significant difference (p > 0.05) was recorded between control and AHE alone treated group in all parameters. (One-way ANOVA followed by Tukey’s multiple comparison tests). Sily-Silymarin